Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. | Br J Cancer | 2022 | 35031764 | PubTator, text mining | PubMed |
| Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway. | Mol Biol Rep | 2022 | 35028860 | PubTator, text mining | PubMed |
| Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies. | Int J Oncol | 2022 | 35014681 | PubTator, text mining | PubMed |
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
| The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We? | Int J Biol Sci | 2022 | 35002508 | PubTator, text mining | PubMed |
| Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure. | Eur J Heart Fail | 2022 | 34989084 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine. | Adv Biol Regul | 2022 | 34916167 | PubTator, text mining | PubMed |
| DNA-assisted site-selective protein modification. | Biopolymers | 2022 | 34878181 | PubTator, text mining | PubMed |
| Disruption of β-Catenin-Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion. | Mol Cancer Res | 2022 | 34799404 | PubTator, text mining | PubMed |
| Serum midkine level might be a diagnostic tool for COVID19 disease in pregnancy: From the disease severity, hospitalization and disease progression respects. | Cytokine | 2022 | 34739899 | PubTator, text mining | PubMed |
| Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix. | J Drug Target | 2022 | 34708678 | PubTator, text mining | PubMed |
| Normal imaging findings after ascending aorta prosthesis implantation on 18F-Fluorodeoxyglucose Positron Emission Tomography with computed tomography. | J Nucl Cardiol | 2022 | 34708302 | PubTator, text mining | PubMed |
| Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase. | Transl Oncol | 2022 | 34649149 | PubTator, text mining | PubMed |
| Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment. | Mov Disord | 2022 | 34637165 | PubTator, text mining | PubMed |
| Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice. | J Bone Miner Res | 2022 | 34633111 | PubTator, text mining | PubMed |
| HOXA11-AS aggravates microglia-induced neuroinflammation after traumatic brain injury. | Neural Regen Res | 2022 | 34558538 | PubTator, text mining | PubMed |
| The lymphatic vasculature: An active and dynamic player in cancer progression. | Med Res Rev | 2022 | 34486138 | PubTator, text mining | PubMed |
| Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains. | Cytotherapy | 2022 | 34483067 | PubTator, text mining | PubMed |
| Protective Effect of Nerium oleander Distillate and Tarantula cubensis Alcoholic Extract on Cancer Biomarkers in Colon and Liver Tissues of Rats with Experimental Colon Cancer. | Anticancer Agents Med Chem | 2022 | 34477527 | PubTator, text mining | PubMed |
| Pivotal Response Treatment with and without robot-assistance for children with autism: a randomized controlled trial. | Eur Child Adolesc Psychiatry | 2022 | 34106357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=48